It is derived from a natural protective compound found in human stomach secretions
As a tri-agonist, it targets three different receptors: the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract Current Pharmaceutical Design, 2011, Volume 17 (Issue 16), Pages 1612-32
238 Although Apo-B particles play a role in clearing LDL-cholesterol, they tend to get trapped in arterial walls, leading to or worsening atherosclerotic disease
In integrative veterinary medicine, I use BPC-157 as an advanced, root-cause support for pets with chronic gut issues, skin flares, inflammatory conditions, or slow healing
The full certificate of analysis for your exact batch is published online and available for verification